4//SEC Filing
Bisgaier Charles PhD 4
Accession 0001596771-18-000013
CIK 0001638287other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:36 PM ET
Size
5.3 KB
Accession
0001596771-18-000013
Insider Transaction Report
Form 4
Bisgaier Charles PhD
DirectorChair & Chief Scientific Off.10% Owner
Transactions
- Award
Stock Option (right to buy)
2018-01-28+48,000→ 48,000 totalExercise: $10.10Exp: 2028-01-27→ Common Stock (48,000 underlying)
Footnotes (1)
- [F1]The option vests in a series of 48 successive equal monthly installments on the last day of each month, commencing on the grant date.
Documents
Issuer
Gemphire Therapeutics Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001381030
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:36 PM ET
- Size
- 5.3 KB